BR0014001A - Chemotherapy potentiation method and treatment of solid tumors - Google Patents

Chemotherapy potentiation method and treatment of solid tumors

Info

Publication number
BR0014001A
BR0014001A BR0014001-5A BR0014001A BR0014001A BR 0014001 A BR0014001 A BR 0014001A BR 0014001 A BR0014001 A BR 0014001A BR 0014001 A BR0014001 A BR 0014001A
Authority
BR
Brazil
Prior art keywords
treatment
chemotherapy
solid tumors
regimen
potentiation
Prior art date
Application number
BR0014001-5A
Other languages
Portuguese (pt)
Inventor
James Joseph Gibbons Jr
Gary Dukart
Judy Lucas
Lisa Anne Speicher
Original Assignee
American Home Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Home Prod filed Critical American Home Prod
Publication of BR0014001A publication Critical patent/BR0014001A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção: "MéTODO DE POTENCIALIZAçãO DE QUIMIOTERAPIA E TRATAMENTO DE TUMORES SóLIDOS". Esta invenção proporciona um método de tratamento de tumores sólidos o qual compreende administrar uma quantidade eficaz de uma combinação de (1) um modificador de biorresposta e (2) um agente quimioterápico. Esta invenção também proporciona um método de potencialização dos efeitos de um regime quimioterápico em um mamífero sob necessidade de tratamento com esse regime, método este que compreende administrar um modificador de biorresposta além de um regime quimioterápico.Invention Patent: "CHEMOTHERAPY POTENTIALIZATION METHOD AND SOLID TUMOR TREATMENT". This invention provides a method of treating solid tumors which comprises administering an effective amount of a combination of (1) a bioresponse modifier and (2) a chemotherapeutic agent. This invention also provides a method of enhancing the effects of a chemotherapeutic regimen in a mammal in need of treatment with that regimen, a method that comprises administering a bio-response modifier in addition to a chemotherapeutic regimen.

BR0014001-5A 1999-09-15 2000-09-12 Chemotherapy potentiation method and treatment of solid tumors BR0014001A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39605199A 1999-09-15 1999-09-15
PCT/US2000/025008 WO2001019399A2 (en) 1999-09-15 2000-09-12 Method of potentiating chemotherapy and treating solid tumors

Publications (1)

Publication Number Publication Date
BR0014001A true BR0014001A (en) 2002-05-21

Family

ID=23565645

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0014001-5A BR0014001A (en) 1999-09-15 2000-09-12 Chemotherapy potentiation method and treatment of solid tumors

Country Status (8)

Country Link
EP (1) EP1214092A2 (en)
JP (1) JP2003509383A (en)
CN (1) CN1391484A (en)
AR (1) AR025659A1 (en)
AU (1) AU7373600A (en)
BR (1) BR0014001A (en)
CA (1) CA2381078A1 (en)
WO (1) WO2001019399A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ299756B6 (en) * 2001-05-16 2008-11-12 Novartis Ag Combination containing N-(5-[4-(4-methyl-piperazino-methyl)benzoylamido]-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidine-amine intended for the treatment of proliferative diseases
CN109601739B (en) * 2019-01-17 2022-10-14 河南湾流生物科技有限公司 Compound amino acid feed additive and preparation method thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2874099A (en) * 1998-02-24 1999-09-06 Dovetail Technologies, Inc. Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof
CN1346282A (en) * 1998-12-23 2002-04-24 G.D.西尔公司 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as combination therapy method in treating neoplasia

Also Published As

Publication number Publication date
AU7373600A (en) 2001-04-17
AR025659A1 (en) 2002-12-11
WO2001019399A3 (en) 2001-12-13
WO2001019399A2 (en) 2001-03-22
CN1391484A (en) 2003-01-15
CA2381078A1 (en) 2001-03-22
EP1214092A2 (en) 2002-06-19
JP2003509383A (en) 2003-03-11

Similar Documents

Publication Publication Date Title
ATE494304T1 (en) IMMUNE-SPECIFIC BINDING ANTIBODIES AGAINST BLYS
BR0009647A (en) Docetaxel in combination with rhumab her2 for the treatment of cancers
BR0209365A (en) Pharmaceutical uses of bisphosphonates
PT696326E (en) UTILIZATION OF NDV IN THE MANUFACTURE OF A CANCER TREATMENT MEDICINE
BR9916518A (en) A method for treating or preventing a neoplasm disorder in a mammal in need of such treatment or prevention, and a combination comprising a cyclooxygenase-2 inhibitor and one or more antineoplastic agents.
WO2003055979A3 (en) ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO BLyS
BR0206639A (en) Sterol Absorption Inhibitor (s) Combinations With Blood Modifier (s) For Treatment Of Vascular Conditions
BR0209147A (en) Combination therapy using anti-egfr antibodies and antihormonal agents
CY1106974T1 (en) MULTIPLE CHINESE TREATMENT FOR WEIGHT LOSS AND THERAPEUTIC TREATMENT
MY124091A (en) Use of peg-ifn-alpha and ribavirin for the treatment of chronic hepatitis c
BR0013219A (en) Methods of treating or inhibiting colon polyps, treating or inhibiting colorectal cancer, using a combination of nsaid and an egfr kinase inhibitor, pharmaceutical composition, and
DE60118172D1 (en) ADMINISTRATION OF A CHEMOSO-PROOF COMPOUND CONTAINING A THIOL GROUP
BR0013122A (en) Cyclobenzaprine for treatment of generalized anxiety disorder and cyclobenzaprine compositions
CY1110894T1 (en) METHODS FOR THE TREATMENT OR PREVENTION OF VASCULAR INFLAMMATION USING STEROLIS ABSORBTOR (S)
BR9709942A (en) Use of a compound pharmaceutical composition packaging and treatment process of human or non-human animal organism to combat or prevent conditions associated with the presence of free radicals in the body
BR0310026A (en) Use of docetaxel / doxorubicin / cyclophosphamide in adjunctive therapy for breast and ovarian cancer
BR8905657A (en) PROCESS TO PREPARE A BIFUNCTIONAL CHELANT, PROCESS TO PREPARE A COMPLEX OF A COMPOUND, PROCESS TO PREPARE A CONJUGATE AND PROCESS TO PREPARE A PHARMACEUTICAL FORMULATION
BR9814419A (en) "combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of proliferative diseases"
PT1007055E (en) UTILIZATION OF AMIFOSTINE
BR0014001A (en) Chemotherapy potentiation method and treatment of solid tumors
EA200100966A1 (en) TREATMENT OF THROMBOSIS BY THE COMBINED APPLICATION OF THE INHIBITOR OF THE FACTOR Xa AND ASPIRIN, THE ACTIVATOR OF A TISSUE PLASMINOGEN (TPA), ANTAGONIST GPIIB / IIIA, A LOW-MOLECULAR HEPARIN OR HEPARIN
BR0317539A (en) Methods and compositions for treating herpes virus infections using selective cyclooxygenase-2 inhibitors or cyclooxygenase-2 inhibitors in combination with antiviral agents
DE60222383D1 (en) MEDICAMENT FOR THE ADMINISTRATION OF AMIFOSTIN AND RELATED ACTIVE SUBSTANCES
IL126159A (en) Pharmaceutical composition containing duloxetine for treating or preventing interstitial cystitis
ATE344664T1 (en) IMPROVED METHOD FOR ERADICATION OF HELICOBACTER PYLORI

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B25D Requested change of name of applicant approved